Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2026-02-20 @ 1:33 PM
Study NCT ID:
NCT00110695
Status:
COMPLETED
Last Update Posted:
2010-03-26
First Post:
2005-05-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer
Sponsor:
NSABP Foundation Inc
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
NSABP FB-AX-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Norman Wolmark, MD
Old Organization:
NSABP Foundation, Inc.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |